Leucemia/Linfoma de células T del adulto y criptococosis sistémica: Reporte de dos casos en un hospital peruano

Milagros Altamirano-Molina, Giancarlo Pérez-Lazo, Ana Alvarez Barcena, Víctor Delgado Gonzáles, Renee Eyzaguirre Zapata

Resumen


La leucemia/linfoma de células T adulto (LLCTA) es una neoplasia linfoide causada por el virus linfotrópico humano de células T tipo 1 (HTLV-1), retrovirus endémico en nuestro país. Tiene una presentación heterogénea, con variedades de pobre pronóstico e infecciones oportunistas que lo ensombrecen aún más. Se presentan dos casos de pacientes con variedades agresivas de la enfermedad (aguda y linfomatosa) complicadas con criptococosis sistémica.
Reforzamos la necesidad de un enfoque diagnóstico completo y un monitoreo continuo de agentes oportunistas en el paciente con LLCTA adaptado a nuestro contexto epidemiológico.


Palabras clave


Leucemia-Linfoma de células T del adulto; Infecciones oportunistas; Criptococosis

Texto completo:

PDF

Referencias


Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL.

Global epidemiology of HTLV-I infection and associated diseases.

Oncogene. 2005; 24(39): 6058–68.

Utsunomiya A, Choi I, Chihara D, Seto M. Recent advances in the

treatment of adult T-cell leukemia-lymphomas. Cancer Sci. 2015;

: 344-351.

Chihara D, Ito H, Matsuda T, Katanoda K, Shibata A, Taniguchi S

et al. Association between decreasing trend in the mortality of

adult T-cell leukemia ⁄ lymphoma and allogeneic hematopoietic

stem cell transplants in Japan: analysis of Japanese vital statistics

and Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Blood Cancer J. 2013; 3(11): e159.

Tsukasaki K, Tobinai K. Human T-cell lymphotropic virus type

I-associated adult T-cell leukemia-lymphoma: new directions in

clinical research. Clin Cancer Res. 2014;20(20):5217-25.

Shimoyama M. Diagnostic criteria and classification of clinical

subtypes of adult T-cell leukaemia-lymphoma. A report from the

Lymphoma Study Group (1984–87). Br J Haematol 1991; 79: 428–37.

Bazarbachi A, Suarez F, Fields P, Hermine O. How I treat adult T-cell

leukemia/lymphoma. Blood. 2011; 118 (7): 1736-45.

Katsuya H, Ishitsuka K. Treatment advances and prognosis for

patients with adult T-cell leukemia-lymphoma. J Clin Exp Hematop.

;57(3):87-97.

Maeda T, Babazono A, Nishi T, Yasui M, Matsuda S, Fushimi k, et

al. The Impact of Opportunistic Infections on Clinical Outcome and

Healthcare Resource Uses for Adult T Cell Leukaemia. Plos One.

; 10(8): 2-12.

Dioverti M, Parikh S, Osmon D, Habermann T, Tande A. Cryptococcus

neoformans infections in patients with lymphoproliferative

neoplasms. Leuk Lymphoma. 2018,6:1-7.

Maeda T, Babazono A, Nishi T, Yasui M, Matsuda S, Fushimi K, et

al. The Impact of Opportunistic Infections on Clinical Outcome and

Healthcare Resource Uses for Adult T Cell Leukaemia. PLoS ONE.

;10(8): e0135042.

Chalkias S, Doweiko J, Eliopoulos G. An enabling act. Open Forum

Infect Dis. 2014; 1(1): ofu008.

Marsh BJ. Infectious complications of human T cell leukemia/

lymphoma virus type I infection. Clin Infect Dis. 1996;23(1):138-45.

Tashiro T, Yamasaki T, Nagai H, Kikuchi H, Nasu M. Immunological

studies on opportunistic infection and the development of adult

T-cell leukemia. Intern Med 1992;31:1132-36.

Rhew DC, Gaultier CR, Daar ES, Zakowski PC, Said J. Infections in

patients with chronic adult T-cell leukemia/lymphoma: Case report

and review. Clin Infect Dis. 1995;21(4):1014-6.

Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T et

al. Long-term study of indolent adult T-cell leukemia-lymphoma.

Blood. 2010;115(22):4337-43.

Malpica L, Pimentel A, Reis I, Gotuzzo E, Lekakis L, Komanduri K.

Epidemiology, clinical features, and outcome of HTLV-1-related

ATLL in an area of prevalence in the United States. Blood Adv.

;2(6), 607-20.

Miyoshi I, Hatakeyama N, Daibata M, Taguchi H. Cutaneous and nodal

cryptococcosis in an ATL Patient. Intern Med. 2006;45(19):1105-06.

Yamada W, Yamada H, Murata K, Kosugi H, Asano Y, Mochizuki

K, Ishida K. Case of cryptococcal choroiditis in adult with

T-cell leukemia/lymphoma. J Infect Chemother. 2018; S1341-

X(18)30190-9.

Suzuki T, Ichiki Y, Kamihira T, Akamine M, Iida M, Ogawa K, Fujisawa

K. A case of hepatic cryptococcosis complicated by adult T-cell

leukemia. Nihon Shokakibyo Gakkai Zasshi. 112(12):2168-75.

Tanaka T, Sekioka T, Usui M, Imashuku S. Opportunistic Infections in

Patients with HTLV-1 Infection. Case Rep Hematol. 2015:943867. .

Concha-Velasco F, González-Lagos E, Seas C, Bustamante B. Factors

associated with early mycological clearance in HIV-associated

cryptococcal meningitis. PLoS One. 2017;12(3): e0174459.

Henao-Martínez AF, Chastain DB, Franco-Paredes C. Treatment of

cryptococcosis in non-HIV immunocompromised patients. Curr Opin

Infect Dis. 2018;31(4):278-85.

Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD. A

systematic review of fluconazole resistance in clinical isolates of

Cryptococcus species. Mycoses. 2018;61(5):290-97.

NCCN Guidelines [Internet]. Clinical Practice Guideliness in

Oncology.T cell-Lyphomas.Version.2019.[citado 1 de agosto de

. Disponible en


Enlaces refback

  • No hay ningún enlace refback.




Copyright (c) 2019 Horizonte Médico (Lima)

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.

La revista es publicada por Facultad de Medicina Humana, Universidad de San Martín de Porres

Dirección: Av. El Corregidor 1531, La Molina. Lima, Perú.
ISSN: 1727-558X (impreso); 2227-3530 (en línea).
DOI: http://doi.org/10.24265/horizmed
Contacto:
horizonte_medico@usmp.pe